tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Can-Fite BioPharma announces group from UCLA demonstrate Piclidenoson efficacy
PremiumThe FlyCan-Fite BioPharma announces group from UCLA demonstrate Piclidenoson efficacy
2M ago
Can-Fite BioPharma files to sell 4.9M American depositary shares
Premium
The Fly
Can-Fite BioPharma files to sell 4.9M American depositary shares
2M ago
Can-Fite BioPharma to present Phase IIa pancreatic cancer study progress
Premium
The Fly
Can-Fite BioPharma to present Phase IIa pancreatic cancer study progress
4M ago
Can-Fite BioPharma trading resumes
PremiumThe FlyCan-Fite BioPharma trading resumes
6M ago
Can-Fite BioPharma announces $3.0M registered direct offering of ADSs
Premium
The Fly
Can-Fite BioPharma announces $3.0M registered direct offering of ADSs
6M ago
Can-Fite BioPharma trading halted, news pending
Premium
The Fly
Can-Fite BioPharma trading halted, news pending
6M ago
Can-Fite announces FDA approved compassionate use treatment of Namodenoson
PremiumThe FlyCan-Fite announces FDA approved compassionate use treatment of Namodenoson
7M ago
Can-Fite’s Namodenoson Shows Promise in Treating Liver Cirrhosis
Premium
Company Announcements
Can-Fite’s Namodenoson Shows Promise in Treating Liver Cirrhosis
8M ago
Can-Fite reports disappearance of decompensated liver cirrhosis episodes
Premium
The Fly
Can-Fite reports disappearance of decompensated liver cirrhosis episodes
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100